Clinical Trial Update: Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining molecular analyses to predict pathways of endocrine resistance after short-term neoadjuvant endocrine therapy in hormo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING